Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Gains from Investment Securities for 5 consecutive years, with $337000.0 as the latest value for Q4 2018.

  • Quarterly Gains from Investment Securities changed N/A to $337000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$25750.0 through Dec 2018, up 92.9% year-over-year, with the annual reading at $16.6 million for FY2025, 27060.66% up from the prior year.
  • Gains from Investment Securities hit $337000.0 in Q4 2018 for Armata Pharmaceuticals, up from $36500.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q3 2017 to a low of -$362750.0 in Q2 2015.
  • Historically, Gains from Investment Securities has averaged $191345.3 across 4 years, with a median of $150856.0 in 2016.
  • Biggest five-year swings in Gains from Investment Securities: surged 363.03% in 2017 and later crashed 99.39% in 2018.
  • Year by year, Gains from Investment Securities stood at $547181.0 in 2015, then crashed by 95.17% to $26419.0 in 2016, then surged by 3952.28% to $1.1 million in 2017, then crashed by 68.52% to $337000.0 in 2018.
  • Business Quant data shows Gains from Investment Securities for ARMP at $337000.0 in Q4 2018, $36500.0 in Q3 2018, and $1450.0 in Q2 2018.